Gim Seow - Titan Pharmaceuticals CEO Board

TTNP Stock  USD 3.98  0.06  1.53%   

CEO

Gim Seow is CEO Board of Titan Pharmaceuticals
Age 42
Address 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
Phone650 244 4990
Webhttps://www.titanpharm.com

Titan Pharmaceuticals Management Efficiency

The company has return on total asset (ROA) of (1.7263) % which means that it has lost $1.7263 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.6899) %, meaning that it created substantial loss on money invested by shareholders. Titan Pharmaceuticals' management efficiency ratios could be used to measure how well Titan Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities. As of 03/01/2025, Return On Tangible Assets is likely to drop to -0.83. In addition to that, Return On Capital Employed is likely to drop to -1.32. As of 03/01/2025, Non Current Liabilities Other is likely to grow to about 1 M, while Total Current Liabilities is likely to drop slightly above 1.6 M.
Titan Pharmaceuticals currently holds 565 K in liabilities with Debt to Equity (D/E) ratio of 0.04, which may suggest the company is not taking enough advantage from borrowing. Titan Pharmaceuticals has a current ratio of 3.0, suggesting that it is liquid enough and is able to pay its financial obligations when due. Note, when we think about Titan Pharmaceuticals' use of debt, we should always consider it together with its cash and equity.

Similar Executives

Found 5 records

CEO Age

Tiago MDPasithea Therapeutics Corp
48
Jeffrey JDIndaptus Therapeutics
58
Adrian GottschalkFoghorn Therapeutics
49
David MBASalarius Pharmaceuticals
62
Bastiaan MScLixte Biotechnology Holdings
53
Titan Pharmaceuticals, Inc., a pharmaceutical company, develops therapeutics for the treatment of chronic diseases. The company was incorporated in 1992 and is based in South San Francisco, California. Titan Pharma operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 11 people. Titan Pharmaceuticals (TTNP) is traded on NASDAQ Exchange in USA. It is located in 400 Oyster Point Boulevard, South San Francisco, CA, United States, 94080 and employs 4 people. Titan Pharmaceuticals is listed under Pharmaceuticals category by Fama And French industry classification.

Management Performance

Titan Pharmaceuticals Leadership Team

Elected by the shareholders, the Titan Pharmaceuticals' board of directors comprises two types of representatives: Titan Pharmaceuticals inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Titan. The board's role is to monitor Titan Pharmaceuticals' management team and ensure that shareholders' interests are well served. Titan Pharmaceuticals' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Titan Pharmaceuticals' outside directors are responsible for providing unbiased perspectives on the board's policies.
Brian Crowley, Senior Administration
Gim Seow, CEO Board
Joe Schrei, Executive Operations
Katherine BeebeDeVarney, COO President
Weei Chay, Chief Officer
Marc MD, Ex Director
David Lazar, Principal Officer
Jennifer Kiernan, Executive Coordinator
Brynner Chiam, Acting Officer
Mike Fritz, National Director

Titan Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Titan Pharmaceuticals a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Additional Tools for Titan Stock Analysis

When running Titan Pharmaceuticals' price analysis, check to measure Titan Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Titan Pharmaceuticals is operating at the current time. Most of Titan Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Titan Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Titan Pharmaceuticals' price. Additionally, you may evaluate how the addition of Titan Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.